Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P276-00 + Gemcitabine in Pancreatic Cancer
NCT00898287Phase 2Completed
- Sponsor
- Piramal Enterprises Limited
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of P276 in pancreatic ductal adenocarcinoma (PDAC), sponsored by Piramal Enterprises Limited. Started May 2009; status: completed.
02
Drugs
P276
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00898287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00898287.